The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-((1,3,6,7-Tetramethoxyxanthone-4-yl)-sulfonyl)-3-(N,N-diethyl-aminocarbonyl)-piperidine ID: ALA1097385
PubChem CID: 46887487
Max Phase: Preclinical
Molecular Formula: C27H34N2O9S
Molecular Weight: 562.64
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)C(=O)C1CCCN(S(=O)(=O)c2c(OC)cc(OC)c3c(=O)c4cc(OC)c(OC)cc4oc23)C1
Standard InChI: InChI=1S/C27H34N2O9S/c1-7-28(8-2)27(31)16-10-9-11-29(15-16)39(32,33)26-22(37-6)14-21(36-5)23-24(30)17-12-19(34-3)20(35-4)13-18(17)38-25(23)26/h12-14,16H,7-11,15H2,1-6H3
Standard InChI Key: YXLGXPDXFHKMCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
5.2487 -5.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8232 -4.6600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9928 -4.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5960 -5.3992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0736 -5.3554 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.2223 -3.9379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0472 -3.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7711 -5.4158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3444 -4.7097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8481 -6.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0206 -6.1040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6203 -6.8231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2753 -6.7972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7954 -6.8349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8705 -7.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0453 -7.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6424 -8.2479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0634 -8.9574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8917 -8.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2909 -8.2258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6609 -9.6775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8360 -9.6890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3156 -9.6520 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9147 -10.3730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4980 -6.0628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4792 -4.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6542 -4.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0975 -6.7847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5184 -7.4901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3437 -7.4805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7463 -6.7593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3236 -6.0477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5712 -6.7482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9933 -7.4571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9741 -6.0283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5904 -8.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0124 -8.8859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8182 -7.4461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2402 -8.1549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18 19 1 0
8 9 1 0
19 20 2 0
20 15 1 0
10 11 2 0
18 21 1 0
4 11 1 0
21 22 1 0
1 2 2 0
19 23 1 0
1 5 1 0
23 24 1 0
10 1 1 0
5 25 1 0
10 13 1 0
5 26 2 0
11 12 1 0
5 27 2 0
25 28 1 0
12 16 1 0
15 13 1 0
2 6 1 0
12 14 2 0
2 3 1 0
25 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
6 7 1 0
31 33 1 0
15 16 2 0
33 34 1 0
33 35 2 0
16 17 1 0
34 36 1 0
4 8 1 0
36 37 1 0
17 18 2 0
34 38 1 0
3 4 2 0
38 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 562.64Molecular Weight (Monoisotopic): 562.1985AlogP: 3.25#Rotatable Bonds: 9Polar Surface Area: 124.82Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 1.97CX LogD: 1.97Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.36Np Likeness Score: -0.51
References 1. Hu H, Liao H, Zhang J, Wu W, Yan J, Yan Y, Zhao Q, Zou Y, Chai X, Yu S, Wu Q.. (2010) First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors., 20 (10): [PMID:20403694 ] [10.1016/j.bmcl.2010.03.101 ] 2. Pokhrel, Laxman and 5 more authors. 2012-10-25 Inhibition of Acyl-CoA: cholesterol acyltransferase (ACAT), overexpression of cholesterol transporter gene, and protection of amyloid β (Aβ) oligomers-induced neuronal cell death by tricyclic pyrone molecules. [PMID:23025824 ] 3. Ting, Pauline C PC and 10 more authors. 2013-02-15 Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors. [PMID:23317570 ] 4. Eguchi, Keisuke K and 10 more authors. 2013-07-01 Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo. [PMID:23665143 ]